GAP

The project GAP focuses on the area of "Patient safety and risk assessment" of the challenge 5 of FP7-ICT. It addresses, via specific workshops and studies, all aspects of risk prediction, evaluation of risk factors, evaluation and management tools designed for the preparation of means that allows an intervention in real situations. The project will evaluate insofar as possible all current solutions resulting from civil and military research on computerized decision-making on the topic of crisis management and, more specifically, major health crises.

The results of the project will add to the decision-making potential of the unit of information collection on health crises (Emergency Operations Facility of the Directorate General of Health and Consumer Protection) which brings together a range of computerized tools for the collection and transmission of information (H.E.O.F). The primary goal of this project is to bring together the emergent concepts which will permit us in the near future to predict, study, control and remedy the most complex of crises, those that jeopardise health. The challenge is to build a genuine system of health and social defence, and its components (concept, organisation, personnel, equipment, training..), at the European and world levels.

The project results should facilitate the creation of this system. At the same time, the partners are aware of the importance of the political decision and commitment. For this reason, GAP is driven from High-level representatives of HealthCare Ministries of EU countries and Associated States (Israel). The consortium and the experts associated with the Support Action GAP represent both of the complementary poles of excellence for the successful execution of this mission.

For further information, please visit:
http://www.gaptheproject.eu

Project co-ordinator:
Departament de Salut (Barcelona, Spain)

Partners:

  • Maccabi Healthcare Services
  • MedCom (Denmark)
  • KADRIS Consultants SARL (France)
  • Ecomit Consulting S.L. (Spain)
  • Ministry of Health (Israel)
  • Institut national de la santé et de la recherche médicale (France)
  • Region Syddanmark (Denmark)
  • Istituto Superiore di Sanità (Italy)
  • Ecole des Hautes Etudes en santé Publique (France)

Timetable: from 01/2008 - to 12/2008

Total cost: € 1.278.980

EC funding: € 930.707

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Coordination and support actions


Related news article:

Most Popular Now

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

Bayer Acquires Blackford Analysis Ltd. B…

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...

Veradigm Announces Strategic Investment …

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...